pI: 7.2971 |
Length (AA): 751 |
MW (Da): 85129 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
58 | 262 | 2c46 (A) | 0 | 199 | 45.00 | 0.0000000028 | 1 | 0.802869 | -1.31 |
96 | 238 | 3rgo (A) | 9 | 151 | 18.00 | 0 | 1 | 0.565813 | -1.66 |
359 | 720 | 3s24 (A) | 229 | 562 | 37.00 | 0 | 1 | 0.838424 | -0.09 |
363 | 737 | 1p16 (A) | 4 | 390 | 29.00 | 0 | 1 | 0.681734 | 0.35 |
365 | 732 | 4pz7 (A) | 4 | 372 | 28.00 | 0 | 1 | 0.724413 | 0.03 |
368 | 625 | 3rtx (A) | 245 | 541 | 41.00 | 0 | 1 | 0.661942 | -0.11 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128005)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G28210 | mRNA capping enzyme family protein |
Arabidopsis thaliana | AT3G09100 | mRNA capping enzyme family protein |
Arabidopsis thaliana | AT5G01290 | mRNA capping enzyme family protein |
Babesia bovis | BBOV_III006110 | mRNA capping enzyme, C-terminal domain containing protein |
Brugia malayi | Bm1_12210 | mRNA capping enzyme, C-terminal domain containing protein |
Candida albicans | CaO19.1261 | mRNA guanylyltransferase/mRNA capping enzyme |
Candida albicans | CaO19.8846 | mRNA guanylyltransferase/mRNA capping enzyme |
Caenorhabditis elegans | CELE_C03D6.3 | Protein CEL-1, isoform B |
Cryptosporidium hominis | Chro.60277 | mRNA capping enzyme alpha subunit |
Cryptosporidium parvum | cgd6_2380 | mRNA capping enzyme; RNA guanylyltransferase Ceg1p |
Dictyostelium discoideum | DDB_G0289199 | hypothetical protein |
Drosophila melanogaster | Dmel_CG1810 | mRNA-capping-enzyme |
Echinococcus granulosus | EgrG_000208300 | mrna capping enzyme |
Entamoeba histolytica | EHI_109940 | mRNA capping enzyme, putative |
Echinococcus multilocularis | EmuJ_000208300 | mrna capping enzyme |
Giardia lamblia | GL50803_17308 | mRNA capping enzyme alpha subunit |
Homo sapiens | ENSG00000111880 | RNA guanylyltransferase and 5'-phosphatase |
Loa Loa (eye worm) | LOAG_08948 | hypothetical protein |
Mus musculus | ENSMUSG00000028274 | RNA guanylyltransferase and 5'-phosphatase |
Neospora caninum | NCLIV_043900 | AT3g09100/MZB10_13, related |
Oryza sativa | 4350086 | Os11g0217500 |
Oryza sativa | 4351709 | Os12g0193200 |
Plasmodium berghei | PBANKA_1028100 | mRNA-capping enzyme subunit alpha, putative |
Plasmodium falciparum | PF3D7_1414600 | mRNA-capping enzyme subunit alpha |
Plasmodium knowlesi | PKNH_1343500 | mRNA-capping enzyme subunit alpha, putative |
Plasmodium vivax | PVX_085720 | mRNA capping enzyme, putative |
Plasmodium yoelii | PY05095 | mRNA capping enzyme, putative |
Saccharomyces cerevisiae | YGL130W | Ceg1p |
Schistosoma japonicum | Sjp_0214610 | mRNA-capping enzyme, putative |
Schistosoma japonicum | Sjp_0301500 | ko:K00987 mRNA guanylyltransferase [EC2.7.7.50], putative |
Schistosoma mansoni | Smp_132720.2 | mRNA-capping enzyme |
Schmidtea mediterranea | mk4.001408.03 | |
Schmidtea mediterranea | mk4.000973.00 | mRNA-capping enzyme |
Schmidtea mediterranea | mk4.012610.01 | |
Schmidtea mediterranea | mk4.006910.02 | |
Schmidtea mediterranea | mk4.006910.03 | mRNA-capping enzyme |
Schmidtea mediterranea | mk4.000973.02 | mRNA-capping enzyme |
Schmidtea mediterranea | mk4.003218.01 | mRNA-capping enzyme |
Schmidtea mediterranea | mk4.017652.00 | |
Schmidtea mediterranea | mk4.021873.01 | |
Schmidtea mediterranea | mk4.001408.02 | mRNA-capping enzyme |
Schmidtea mediterranea | mk4.006903.00 | mRNA-capping enzyme |
Schmidtea mediterranea | mk4.001439.01 | mRNA-capping enzyme |
Toxoplasma gondii | TGME49_305320 | mRNA capping enzyme |
Theileria parva | TP02_0352 | mRNA capping enzyme, putative |
Trichomonas vaginalis | TVAG_187730 | mRNA capping enzyme, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_C03D6.3 | Caenorhabditis elegans | embryonic arrest | wormbase |
CELE_C03D6.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C03D6.3 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C03D6.3 | Caenorhabditis elegans | slow growth | wormbase |
YGL130W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_305320 | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.